Immune dysregulation of pemphigus in humans and mice

Journal of Dermatology

Volumn 37, Issue 3, 2010, Pages 205-213

  Yokoyama, Tomoaki ^a   Amagai, Masayuki ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Autoantibodies; Autoimmunity; Pemphigus; Regulatory; Self tolerance; T lymphocytes

Indexed keywords

AUTOANTIBODY; DESMOGLEIN 1; EPITOPE; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INTERACTION; HELPER CELL; HUMAN; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; NONHUMAN; PEMPHIGUS VULGARIS; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; ANTIGENS, CD40; AUTOANTIBODIES; B-LYMPHOCYTES; BLISTER; DESMOGLEIN 3; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INTERLEUKIN-2; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; PEMPHIGUS; T-LYMPHOCYTES, REGULATORY;

EID: 77649196125     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2009.00797.x     Document Type: Review

References (67)

1. Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity 2008 28 : 18 28.
2. Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: learning self-control in the thymus. Nat Rev Immunol 2005 5 : 772 782.
3. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008 133 : 775 787.
4. Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991 67 : 869 877.
5. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006 355 : 1800 1810.
6. Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998 281 : 96 99.
7. Lougaris V, Badolato R, Ferrari S, Plebani A. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features. Immunol Rev 2005 203 : 48 66.
8. O'Neill SK, Shlomchik MJ, Glant TT, Cao Y, Doodes PD, Finnegan A. Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis. J Immunol 2005 174 : 3781 3788.
9. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001 1 : 147 153.
10. Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 2000 105 : 625 631.
11. Aoki-Ota M, Tsunoda K, Ota T et al. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice. Br J Dermatol 2004 151 : 346 354.
12. Ohyama M, Amagai M, Tsunoda K et al. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. J Invest Dermatol 2002 118 : 199 204.
13. Tsunoda K, Ota T, Suzuki H et al. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris. Eur J Immunol 2002 32 : 627 633.
14. Nishifuji K, Amagai M, Kuwana M, Iwasaki T, Nishikawa T. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production. J Invest Dermatol 2000 114 : 88 94.
15. Takahashi H, Amagai M, Nishikawa T, Fujii Y, Kawakami Y, Kuwana M. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J Immunol 2008 181 : 1526 1535.
16. Aoki-Ota M, Kinoshita M, Ota T et al. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model. J Invest Dermatol 2006 126 : 105 113.
17. Zhai Y, Meng L, Gao F, Wang Y, Busuttil RW, Kupiec-Weglinski JW. CD4+ T regulatory cell induction and function in transplant recipients after CD154 blockade is TLR4 independent. J Immunol 2006 176 : 5988 5994.
18. Meng L, Wu Z, Wang Y et al. Differential impact of CD154 costimulation blockade on alloreactive effector and regulatory T cells in murine renal transplant recipients. Transplantation 2008 85 : 1332 1338.
19. Derbinski J, Pinto S, Rösch S, Hexel K, Kyewski B. Promiscuous gene expression patterns in single medullary thymic epithelial cells argue for a stochastic mechanism. Proc Natl Acad Sci USA 2008 105 : 657 662.
20. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immun 2003 4 : 350 354.
21. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299 : 1057 1061.
22. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 2003 4 : 330 336.
23. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immun 2007 8 : 191 197.
24. Lahl K, Loddenkemper C, Drouin C et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 2007 204 : 57 63.
25. Zhou X, Bailey-Bucktrout SL, Jeker LT et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immun 2009 10 : 1000 1007.
26. Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009 30 : 626 635.
27. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006 212 : 28 50.
28. Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001 182 : 207 214.
29. Ahmed AR, Wagner R, Khatri K et al. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1991 88 : 5056 5060.
30. Niizeki H, Inoko H, Mizuki N et al. HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanese pemphigus vulgaris patients by the PCR-RFLP method. Tissue Antigens 1994 44 : 248 251.
31. Niizeki H, Inoko H, Narimatsu H et al. HLA class II antigens are associated with Japanese pemphigus patients. Hum Immunol 1991 31 : 246 250.
32. Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol 2003 170 : 635 642.
33. Veldman CM, Gebhard KL, Uter W et al. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol 2004 172 : 3883 3892.
34. Veldman C, Höhne A, Dieckmann D, Schuler G, Hertl M. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris. J Immunol 2004 172 : 6468 6475.
35. Veldman C, Pahl A, Hertl M. Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3. Immunology 2009 127 : 40 49.
36. Veldman C, Pahl A, Beissert S et al. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol 2006 176 : 3215 3222.
37. Sugiyama H, Matsue H, Nagasaka A et al. CD4+CD25(high) regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology (Basel) 2007 214 : 210 220.
38. Ota T, Aoki-Ota M, Tsunoda K, Nishikawa T, Koyasu S, Amagai M. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance. Int Immunol 2008 20 : 1351 1360.
39. Seo S-j, Fields ML, Buckler JL et al. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 2002 16 : 535 546.
40. Goodnow CC. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci USA 1996 93 : 2264 2271.
41. Nemazee D. Receptor selection in B and T lymphocytes. Annu Rev Immunol 2000 18 : 19 51.
42. Cambier JC, Gauld SB, Merrell KT, Vilen BJ. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat Rev Immunol 2007 7 : 633 643.
43. Tsunoda K, Ota T, Aoki M et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003 170 : 2170 2178.
44. Ota T, Aoki-Ota M, Tsunoda K et al. Auto-reactive B cells against peripheral antigen, desmoglein 3, escape from tolerance mechanism. Int Immunol 2004 16 : 1487 1495.
45. Ahmed AR, Mohimen A, Yunis EJ et al. Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients. J Exp Med 1993 177 : 419 424.
46. Brandsen R, Frusic-Zlotkin M, Lyubimov H et al. Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting. J Am Acad Dermatol 1997 36 : 44 52.
47. Torzecka JD, Woźniak K, Kowalewski C et al. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development? Arch Dermatol Res 2007 299 : 239 243.
48. Diaz LA, Prisayanh PS, Dasher DA et al. The IgM anti-desmoglein 1 response distinguishes Brazilian pemphigus foliaceus (fogo selvagem) from other forms of pemphigus. J Invest Dermatol 2008 128 : 667 675.
49. Payne AS, Ishii K, Kacir S et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005 115 : 888 899.
50. Qian Y, Diaz LA, Ye J, Clarke SH. Dissecting the anti-desmoglein autoreactive B cell repertoire in pemphigus vulgaris patients. J Immunol 2007 178 : 5982 5990.
51. Ishii K, Lin C, Siegel DL, Stanley JR. Isolation of pathogenic monoclonal anti-desmoglein 1 human antibodies by phage display of pemphigus foliaceus autoantibodies. J Invest Dermatol 2008 128 : 939 948.
52. Futei Y, Amagai M, Sekiguchi M, Nishifuji K, Fujii Y, Nishikawa T. Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. J Invest Dermatol 2000 115 : 829 834.
53. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 2003 197 : 1501 1510.
54. Payne AS, Siegel DL, Stanley JR. Targeting pemphigus autoantibodies through their heavy-chain variable region genes. J Invest Dermatol 2007 127 : 1681 1691.
55. Ozawa M, Kemler R. Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J Cell Biol 1990 111 : 1645 1650.
56. Posthaus H, Dubois CM, Müller E. Novel insights into cadherin processing by subtilisin-like convertases. FEBS Lett 2003 536 : 203 208.
57. Wahl JK, Kim YJ, Cullen JM, Johnson KR, Wheelock MJ. N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane. J Biol Chem 2003 278 : 17269 17276.
58. Sharma P, Choi E, Kuroda K, Hachiya T, Ishii K, Payne A. Pathogenic anti-desmoglein MAbs show variable ELISA activity because of preferential binding of mature versus proprotein isoforms of desmoglein 3. J Invest Dermatol 2009 129 : 2309 2312.
59. Yokouchi M, Saleh M, Kuroda K et al. Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 2009 129 : 2156 2166.
60. Yamagami J, Kacir S, Ishii K, Payne AS, Siegel DL, Stanley JR. Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus. J Immunol 2009 183 : 5615 5621.
61. Chan LS, Vanderlugt CJ, Hashimoto T et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998 110 : 103 109.
62. Tchernev G, Orfanos CE. Antigen mimicry, epitope spreading and the pathogenesis of pemphigus. Tissue Antigens 2006 68 : 280 286.
63. Ishii K, Amagai M, Ohata Y et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol 2000 42 (5 Pt 2 859 861.
64. Salato VK, Hacker-Foegen MK, Lazarova Z, Fairley JA, Lin M-S. Role of intramolecular epitope spreading in pemphigus vulgaris. Clin Immunol 2005 116 : 54 64.
65. Weitz D, Bystryn J-C. Frequency of shifts over time in the profile of antidesmoglein antibodies in pemphigus vulgaris. Arch Dermatol 2007 143 : 1073 1074.
66. Takahashi H, Kuwana M, Amagai M. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris. J Immunol 2009 182 : 1740 1745.
67. Roosnek E, Lanzavecchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 1991 173 : 487 489.